ArticleMedicine2026
Determinants of hospitalization expenses in primary arthroscopic stabilization for recurrent shoulder anterior instability: A retrospective analysis.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
To identify the factors affecting hospital cost associated with primary arthroscopic stabilization for recurrent shoulder anterior instability. The clinical data of patients with symptoms of recurrent glenohumeral anterior stability who underwent arthroscopic stabilization at a single institution between January 2020 and April 2022 were collected retrospectively. Surgical information and patient characteristics were recorded. Variations in hospital hospitalization expenses were identified and extracted from the medical and billing record keeping system at the hospital. Sixty-one cases of recurrent anterior instability of the glenohumeral joint were identified in 59 patients during the study period. There were no significant differences in hospitalization expenses between the Arthroscopic Bankart repair and Arthroscopic Latarjet groups (P = .624), nor across the different periods (P = .54). However, compared with the minority group, the majority group required a higher number of surgical procedures (1 [1, 1.5] vs 2 [1, 2], P = .011) and had longer operative durations (120.00 [107.00, 135.00] minutes vs 162.50 [130.00, 222.50] minutes, P = .001). Total hospitalization expenses were significantly higher in the majority group (10,144.23 ± 1795.78 United States dollar [USD]) than in the minority group (9042.87 ± 943.22 USD) (P = .003), driven by increased costs for implants (3848.84 ± 855.72 USD vs 4623.81 ± 1175.04 USD, P = .005), consumables (6886.56 ± 1013.82 USD vs 7649.36 ± 1620.16 USD, P = .028), anesthesia (371.98 [357.98, 379.40] USD vs 400.82 [371.98, 429.66] USD, P = .001), medications (524.45 [427.86, 631.29] USD vs 623.39 [515.35, 824.74] USD, P = .02), and anesthetics (168.83 ± 44.55 USD vs 213.83 ± 66.82 USD, P = .003). No significant differences were observed between the minority and majority groups in operation expenses, non-implanted consumables, perioperative drug costs, nursing and examination fees, or days of hospitalization (all P > .05). Patients who experienced 3 or more recurrent dislocations prior to primary arthroscopic stabilization incurred significantly higher hospitalization expenses, driven by increased implant use and prolonged operative time. These findings suggest that earlier surgical intervention in patients with recurrent anterior shoulder instability may help reduce procedural complexity and associated costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.